Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC29H23N5O3 |
InChIKeyUWMIICSPAFDEMX-UHFFFAOYSA-N |
CAS Registry1804982-31-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | China | 25 Jan 2016 |





